nodes	percent_of_prediction	percent_of_DWPC	metapath
Vitamin E—GSTO1—knee—psoriatic arthritis	0.13	0.277	CbGeAlD
Vitamin E—GSTO1—skeletal joint—psoriatic arthritis	0.0934	0.199	CbGeAlD
Vitamin E—GCLC—Apoptosis-related network due to altered Notch3 in ovarian cancer—CARD14—psoriatic arthritis	0.0606	0.123	CbGpPWpGaD
Vitamin E—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CARD14—psoriatic arthritis	0.037	0.075	CbGpPWpGaD
Vitamin E—SEC14L4—tendon—psoriatic arthritis	0.0314	0.0667	CbGeAlD
Vitamin E—DGKA—skin of body—psoriatic arthritis	0.0269	0.0572	CbGeAlD
Vitamin E—PPP2CA—skin of body—psoriatic arthritis	0.0266	0.0565	CbGeAlD
Vitamin E—HMOX1—Overview of nanoparticle effects—CRP—psoriatic arthritis	0.0261	0.053	CbGpPWpGaD
Vitamin E—HMOX1—skin of body—psoriatic arthritis	0.0196	0.0417	CbGeAlD
Vitamin E—PPP2CB—tendon—psoriatic arthritis	0.0172	0.0365	CbGeAlD
Vitamin E—HMOX1—tendon—psoriatic arthritis	0.0149	0.0317	CbGeAlD
Vitamin E—GSTO1—skin of body—psoriatic arthritis	0.0141	0.03	CbGeAlD
Vitamin E—GCLC—tendon—psoriatic arthritis	0.0129	0.0275	CbGeAlD
Vitamin E—PRKCA—skin of body—psoriatic arthritis	0.0126	0.0267	CbGeAlD
Vitamin E—HMOX1—Overview of nanoparticle effects—TNF—psoriatic arthritis	0.0118	0.024	CbGpPWpGaD
Vitamin E—GSTM3—tendon—psoriatic arthritis	0.0115	0.0245	CbGeAlD
Vitamin E—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.0109	0.0222	CbGpPWpGaD
Vitamin E—GSTO1—tendon—psoriatic arthritis	0.0107	0.0228	CbGeAlD
Vitamin E—PRKCB—Activation of NF-kappaB in B cells—REL—psoriatic arthritis	0.00992	0.0201	CbGpPWpGaD
Vitamin E—SOD1—tendon—psoriatic arthritis	0.00988	0.021	CbGeAlD
Vitamin E—PRKCA—ATF-2 transcription factor network—IL23A—psoriatic arthritis	0.00978	0.0198	CbGpPWpGaD
Vitamin E—PRKCA—tendon—psoriatic arthritis	0.00956	0.0203	CbGeAlD
Vitamin E—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.00881	0.0179	CbGpPWpGaD
Vitamin E—HMOX1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.0088	0.0178	CbGpPWpGaD
Vitamin E—NQO1—skin of body—psoriatic arthritis	0.00865	0.0184	CbGeAlD
Vitamin E—PRKCA—Canonical NF-kappaB pathway—NOD2—psoriatic arthritis	0.00782	0.0159	CbGpPWpGaD
Vitamin E—GSTP1—skin of body—psoriatic arthritis	0.00773	0.0164	CbGeAlD
Vitamin E—PPP2CB—MAP kinase activation in TLR cascade—NOD2—psoriatic arthritis	0.00726	0.0147	CbGpPWpGaD
Vitamin E—PRKCB—B Cell Receptor Signaling Pathway—REL—psoriatic arthritis	0.0072	0.0146	CbGpPWpGaD
Vitamin E—PPP2CA—MAP kinase activation in TLR cascade—NOD2—psoriatic arthritis	0.0068	0.0138	CbGpPWpGaD
Vitamin E—PPP2CA—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.00676	0.0137	CbGpPWpGaD
Vitamin E—NQO1—tendon—psoriatic arthritis	0.00658	0.014	CbGeAlD
Vitamin E—PPP2CA—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.00638	0.0129	CbGpPWpGaD
Vitamin E—DGKA—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriatic arthritis	0.00591	0.012	CbGpPWpGaD
Vitamin E—GSTP1—tendon—psoriatic arthritis	0.00588	0.0125	CbGeAlD
Vitamin E—SOD1—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.00587	0.0119	CbGpPWpGaD
Vitamin E—PPP2CB—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.00575	0.0117	CbGpPWpGaD
Vitamin E—PPP2CA—TRAF6 Mediated Induction of proinflammatory cytokines—NOD2—psoriatic arthritis	0.00539	0.0109	CbGpPWpGaD
Vitamin E—PPP2CB—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.0052	0.0105	CbGpPWpGaD
Vitamin E—PPP2CB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.00515	0.0104	CbGpPWpGaD
Vitamin E—PPP2CB—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.00506	0.0103	CbGpPWpGaD
Vitamin E—PPP2CB—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.00488	0.0099	CbGpPWpGaD
Vitamin E—PPP2CA—MyD88 cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.00487	0.00988	CbGpPWpGaD
Vitamin E—PPP2CA—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.00483	0.00979	CbGpPWpGaD
Vitamin E—PPP2CB—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.0048	0.00973	CbGpPWpGaD
Vitamin E—SOD1—Folate Metabolism—CRP—psoriatic arthritis	0.00477	0.00967	CbGpPWpGaD
Vitamin E—PPP2CA—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.00474	0.00961	CbGpPWpGaD
Vitamin E—PRKCB—Downstream signaling events of B Cell Receptor (BCR)—REL—psoriatic arthritis	0.00466	0.00945	CbGpPWpGaD
Vitamin E—PPP2CB—MyD88-independent cascade—NOD2—psoriatic arthritis	0.00461	0.00934	CbGpPWpGaD
Vitamin E—PPP2CA—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.00457	0.00927	CbGpPWpGaD
Vitamin E—PRKCB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.00451	0.00915	CbGpPWpGaD
Vitamin E—PPP2CA—MyD88:Mal cascade initiated on plasma membrane—NOD2—psoriatic arthritis	0.0045	0.00911	CbGpPWpGaD
Vitamin E—SOD1—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.00435	0.00882	CbGpPWpGaD
Vitamin E—PPP2CA—MyD88-independent cascade—NOD2—psoriatic arthritis	0.00431	0.00874	CbGpPWpGaD
Vitamin E—PRKCB—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.0043	0.00871	CbGpPWpGaD
Vitamin E—PPP2CB—Costimulation by the CD28 family—HLA-DRB1—psoriatic arthritis	0.00423	0.00858	CbGpPWpGaD
Vitamin E—PPP2CB—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.00414	0.0084	CbGpPWpGaD
Vitamin E—HMOX1—Fluticasone Propionate—Methylprednisolone—psoriatic arthritis	0.00414	0.114	CbGdCrCtD
Vitamin E—PRKCB—B Cell Activation—REL—psoriatic arthritis	0.00412	0.00835	CbGpPWpGaD
Vitamin E—HMOX1—Fluticasone Propionate—Betamethasone—psoriatic arthritis	0.00408	0.113	CbGdCrCtD
Vitamin E—HMOX1—Fluticasone Propionate—Dexamethasone—psoriatic arthritis	0.00408	0.113	CbGdCrCtD
Vitamin E—GCLC—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.00401	0.00814	CbGpPWpGaD
Vitamin E—HMOX1—Fluticasone Propionate—Triamcinolone—psoriatic arthritis	0.00398	0.11	CbGdCrCtD
Vitamin E—PPP2CA—Costimulation by the CD28 family—HLA-DRB1—psoriatic arthritis	0.00396	0.00804	CbGpPWpGaD
Vitamin E—PPP2CB—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.0039	0.0079	CbGpPWpGaD
Vitamin E—PPP2CA—Activated TLR4 signalling—NOD2—psoriatic arthritis	0.00388	0.00787	CbGpPWpGaD
Vitamin E—SOD1—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.00379	0.00769	CbGpPWpGaD
Vitamin E—PPP2CB—Monoamine Transport—TNF—psoriatic arthritis	0.00366	0.00741	CbGpPWpGaD
Vitamin E—PPP2CA—Toll Like Receptor 4 (TLR4) Cascade—NOD2—psoriatic arthritis	0.00365	0.0074	CbGpPWpGaD
Vitamin E—PPP2CB—Platelet homeostasis—NOS2—psoriatic arthritis	0.00361	0.00732	CbGpPWpGaD
Vitamin E—GCLC—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriatic arthritis	0.00358	0.00726	CbGpPWpGaD
Vitamin E—PPP2CB—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.00347	0.00704	CbGpPWpGaD
Vitamin E—PPP2CA—Platelet homeostasis—NOS2—psoriatic arthritis	0.00338	0.00686	CbGpPWpGaD
Vitamin E—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—psoriatic arthritis	0.00336	0.00681	CbGpPWpGaD
Vitamin E—PPP2CA—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.00325	0.00659	CbGpPWpGaD
Vitamin E—ALOX5—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.00312	0.00633	CbGpPWpGaD
Vitamin E—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.00304	0.00617	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—MEFV—psoriatic arthritis	0.00299	0.00605	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—MEFV—psoriatic arthritis	0.0028	0.00567	CbGpPWpGaD
Vitamin E—SOD1—Vitamin B12 Metabolism—TNF—psoriatic arthritis	0.00266	0.00538	CbGpPWpGaD
Vitamin E—PRKCA—Canonical NF-kappaB pathway—TNF—psoriatic arthritis	0.00252	0.0051	CbGpPWpGaD
Vitamin E—NQO1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.00245	0.00497	CbGpPWpGaD
Vitamin E—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.00245	0.00497	CbGpPWpGaD
Vitamin E—PRKCA—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.00239	0.00484	CbGpPWpGaD
Vitamin E—PRKCA—TCR signaling in naïve CD4+ T cells—HLA-DRB1—psoriatic arthritis	0.00229	0.00464	CbGpPWpGaD
Vitamin E—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriatic arthritis	0.00219	0.00444	CbGpPWpGaD
Vitamin E—PRKCA—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.00218	0.00442	CbGpPWpGaD
Vitamin E—SOD1—Folate Metabolism—TNF—psoriatic arthritis	0.00216	0.00438	CbGpPWpGaD
Vitamin E—PRKCB—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.00213	0.00433	CbGpPWpGaD
Vitamin E—HMOX1—Betamethasone—Methylprednisolone—psoriatic arthritis	0.0021	0.058	CbGdCrCtD
Vitamin E—HMOX1—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.0021	0.058	CbGdCrCtD
Vitamin E—PRKCA—DAP12 interactions—HLA-C—psoriatic arthritis	0.00208	0.00421	CbGpPWpGaD
Vitamin E—HMOX1—Betamethasone—Dexamethasone—psoriatic arthritis	0.00207	0.0571	CbGdCrCtD
Vitamin E—HMOX1—Dexamethasone—Betamethasone—psoriatic arthritis	0.00207	0.0571	CbGdCrCtD
Vitamin E—HMOX1—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00202	0.0557	CbGdCrCtD
Vitamin E—HMOX1—Betamethasone—Triamcinolone—psoriatic arthritis	0.00202	0.0557	CbGdCrCtD
Vitamin E—HMOX1—Betamethasone—Prednisone—psoriatic arthritis	0.00192	0.0529	CbGdCrCtD
Vitamin E—HMOX1—Dexamethasone—Prednisone—psoriatic arthritis	0.00192	0.0529	CbGdCrCtD
Vitamin E—HMOX1—Betamethasone—Prednisolone—psoriatic arthritis	0.00187	0.0516	CbGdCrCtD
Vitamin E—HMOX1—Dexamethasone—Prednisolone—psoriatic arthritis	0.00187	0.0516	CbGdCrCtD
Vitamin E—DGKA—Hemostasis—NOS2—psoriatic arthritis	0.00187	0.00379	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—MEFV—psoriatic arthritis	0.00181	0.00367	CbGpPWpGaD
Vitamin E—PRKCB—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.00176	0.00357	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—MEFV—psoriatic arthritis	0.00174	0.00353	CbGpPWpGaD
Vitamin E—SOD1—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.00172	0.00348	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—REL—psoriatic arthritis	0.00166	0.00337	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—MEFV—psoriatic arthritis	0.00163	0.0033	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—REL—psoriatic arthritis	0.00159	0.00323	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—MEFV—psoriatic arthritis	0.00158	0.0032	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—HLA-C—psoriatic arthritis	0.00153	0.0031	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—HLA-C—psoriatic arthritis	0.00153	0.0031	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—REL—psoriatic arthritis	0.00149	0.00303	CbGpPWpGaD
Vitamin E—PPP2CA—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.00147	0.00298	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—HLA-C—psoriatic arthritis	0.00147	0.00298	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—HLA-C—psoriatic arthritis	0.00143	0.0029	CbGpPWpGaD
Vitamin E—ALOX5—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.00141	0.00286	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—HLA-C—psoriatic arthritis	0.00137	0.00279	CbGpPWpGaD
Vitamin E—PRKCA—Spinal Cord Injury—NOS2—psoriatic arthritis	0.00137	0.00278	CbGpPWpGaD
Vitamin E—PRKCA—Cardiac Hypertrophic Response—TNF—psoriatic arthritis	0.00125	0.00254	CbGpPWpGaD
Vitamin E—PRKCA—DAP12 interactions—HLA-B—psoriatic arthritis	0.00123	0.00249	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—NOD2—psoriatic arthritis	0.00112	0.00228	CbGpPWpGaD
Vitamin E—PRKCA—Downstream signaling in naïve CD8+ T cells—TNF—psoriatic arthritis	0.00108	0.00219	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—NOD2—psoriatic arthritis	0.00105	0.00213	CbGpPWpGaD
Vitamin E—PRKCB—MAPK Signaling Pathway—TNF—psoriatic arthritis	0.00101	0.00205	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—REL—psoriatic arthritis	0.00101	0.00204	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—REL—psoriatic arthritis	0.000967	0.00196	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—HLA-C—psoriatic arthritis	0.000927	0.00188	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—MEFV—psoriatic arthritis	0.000919	0.00186	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—REL—psoriatic arthritis	0.000906	0.00184	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—HLA-B—psoriatic arthritis	0.000904	0.00183	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000904	0.00183	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—HLA-C—psoriatic arthritis	0.00089	0.0018	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000868	0.00176	CbGpPWpGaD
Vitamin E—SOD1—Hemostasis—NOS2—psoriatic arthritis	0.000853	0.00173	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—HLA-B—psoriatic arthritis	0.000847	0.00172	CbGpPWpGaD
Vitamin E—PRKCB—Hemostasis—NOS2—psoriatic arthritis	0.000843	0.00171	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—HLA-C—psoriatic arthritis	0.000834	0.00169	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000813	0.00165	CbGpPWpGaD
Vitamin E—PPP2CB—Hemostasis—NOS2—psoriatic arthritis	0.000809	0.00164	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—HLA-C—psoriatic arthritis	0.000807	0.00164	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—CRP—psoriatic arthritis	0.000799	0.00162	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	0.000765	0.00155	CbGpPWpGaD
Vitamin E—PPP2CA—Hemostasis—NOS2—psoriatic arthritis	0.000758	0.00154	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—CRP—psoriatic arthritis	0.000748	0.00152	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	0.000735	0.00149	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	0.000688	0.0014	CbGpPWpGaD
Vitamin E—GSTO1—Disease—NOS2—psoriatic arthritis	0.000686	0.00139	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—NOD2—psoriatic arthritis	0.000682	0.00138	CbGpPWpGaD
Vitamin E—PRKCA—Spinal Cord Injury—TNF—psoriatic arthritis	0.00068	0.00138	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—NOD2—psoriatic arthritis	0.000655	0.00133	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—NOD2—psoriatic arthritis	0.000613	0.00124	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—NOD2—psoriatic arthritis	0.000594	0.0012	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—HLA-B—psoriatic arthritis	0.000548	0.00111	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—HLA-B—psoriatic arthritis	0.000526	0.00107	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—REL—psoriatic arthritis	0.000511	0.00104	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—HLA-B—psoriatic arthritis	0.000493	0.001	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—CRP—psoriatic arthritis	0.000485	0.000982	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—HLA-B—psoriatic arthritis	0.000477	0.000968	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—HLA-C—psoriatic arthritis	0.00047	0.000953	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—CRP—psoriatic arthritis	0.000465	0.000943	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—HLA-DRB1—psoriatic arthritis	0.000464	0.000941	CbGpPWpGaD
Vitamin E—PRKCA—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	0.000463	0.000938	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—HLA-DRB1—psoriatic arthritis	0.000446	0.000903	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—CRP—psoriatic arthritis	0.000436	0.000884	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—NOS2—psoriatic arthritis	0.000427	0.000867	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—CRP—psoriatic arthritis	0.000422	0.000856	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—HLA-DRB1—psoriatic arthritis	0.000417	0.000846	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—NOS2—psoriatic arthritis	0.000392	0.000794	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—NOS2—psoriatic arthritis	0.000367	0.000744	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—NOD2—psoriatic arthritis	0.000346	0.000701	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—HLA-B—psoriatic arthritis	0.000278	0.000564	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—CRP—psoriatic arthritis	0.000246	0.000498	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—HLA-DRB1—psoriatic arthritis	0.000235	0.000477	CbGpPWpGaD
Vitamin E—PRKCA—Disease—NOS2—psoriatic arthritis	0.000207	0.00042	CbGpPWpGaD
